India Pesticides Limited

NSE:IPL.NS

199.58 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2,287.82,203.61,263.21,506.82,019.72,014.351,981.82,176.372,506.612,184.571,703.651,900.331,784.741,702.941,575.551,575.551,669.221,669.221,299.361,299.361,098.7751,098.775
Cost of Revenue 1,464.81,534.2825.6709.51,288.81,313.461,090.561,201.951,431.51,097.51,098.92842.65829.43778.53789.86791784.37784.37688.715688.715592.875592.875
Gross Profit 823669.4437.6797.3730.9700.89891.24974.421,075.111,087.07604.731,057.68955.31924.41785.69784.55884.85884.85610.645610.645505.9505.9
Gross Profit Ratio 0.360.3040.3460.5290.3620.3480.450.4480.4290.4980.3550.5570.5350.5430.4990.4980.530.530.470.470.460.46
Reseach & Development Expenses 000000000000002.632.272.452.450.0850.0850.090.09
General & Administrative Expenses 00402.1000361.03000433.1700062.1764.6353.6753.6746.75546.75539.11539.115
Selling & Marketing Expenses 0036.800021.3300011.270004.8254.8253.563.562.772.771.931.93
SG&A 532.3429.6438.9357.7358.2379.9382.36418.49458.43444.72444.44367.89343.3301.9666.99569.45557.2357.2349.52549.52541.04541.045
Other Expenses 037.43640.341.332.7830.1345.9123.6432.66-82.8413.3238.537.8600000000
Operating Expenses 532.3429.6438.9505.3498.2508.95500.36539.63577.4554.87158.43467.76425.88389.39374.9373.5394.89394.89315.9315.9312.895312.895
Operating Income 290.7239.8-1.3332.3274224.72421.01480.7521.35564.86427.75602.94567.93572.88404.09404.35480.525480.525263.48263.48181.935181.935
Operating Income Ratio 0.1270.109-0.0010.2210.1360.1120.2120.2210.2080.2590.2510.3170.3180.3360.2560.2570.2880.2880.2030.2030.1660.166
Total Other Income Expenses Net 45.326.821.4-7.4-8.8-13.41-15.2-17.55-20.06-18.73-28.1-12.43-4.31-116.4456.4458.5058.50521.97521.975-0.545-0.545
Income Before Tax 336266.620.1324.9265.2211.31405.81463.15501.29546.13399.65590.51563.62561.88410.535410.795489.03489.03285.455285.455181.39181.39
Income Before Tax Ratio 0.1470.1210.0160.2160.1310.1050.2050.2130.20.250.2350.3110.3160.330.2610.2610.2930.2930.220.220.1650.165
Income Tax Expense 76.971.89.58570.256.8104.58115.17129.1135.1692.92158.83142.74141.67100.47100.56126.545126.54566.04566.04546.88546.885
Net Income 259.1194.810.6239.9195155.2301.23347.8372.19410.97306.73431.68420.88420.21310.065310.235362.485362.485219.41219.41134.505134.505
Net Income Ratio 0.1130.0880.0080.1590.0970.0770.1520.160.1480.1880.180.2270.2360.2470.1970.1970.2170.2170.1690.1690.1220.122
EPS 2.251.690.0922.081.691.342.63.023.233.572.663.753.663.762.782.783.253.251.971.971.211.21
EPS Diluted 2.251.690.0922.081.691.342.63.023.233.562.653.753.663.762.782.783.253.251.971.971.211.21
EBITDA 389.4281.438.3371310.9260.21451.49511.26549.13589.83454.47625.23586.44590.42418.74419496.5496.5276.11276.11194.585194.585
EBITDA Ratio 0.170.1280.030.2460.1540.1290.2280.2350.2190.270.2670.3290.3290.3470.2660.2660.2970.2970.2120.2120.1770.177